Trypanosoma brucei, the parasite behind African sleeping sickness, relies on the flagellum attachment zone (FAZ) for flagellum attachment and cell division. Depleting the FAZ protein FAZ1 causes cytokinesis defects, highlighting its vital role. Find out more: https://bit.ly/47ZXp1w #ECACC
November 5, 2026 at 4:09 PM
Trypanosoma brucei, the parasite behind African sleeping sickness, relies on the flagellum attachment zone (FAZ) for flagellum attachment and cell division. Depleting the FAZ protein FAZ1 causes cytokinesis defects, highlighting its vital role. Find out more: https://bit.ly/47ZXp1w #ECACC
On World Cancer Research Day, we recognised the researchers driving progress in cancer research. Discover how authenticated ECACC cell line models support high-quality cancer studies.
Read more: https://bit.ly/3UtCdOa
#WorldCancerResearchDay #CancerResearch #ECACC
Read more: https://bit.ly/3UtCdOa
#WorldCancerResearchDay #CancerResearch #ECACC
October 19, 2026 at 8:52 AM
On World Cancer Research Day, we recognised the researchers driving progress in cancer research. Discover how authenticated ECACC cell line models support high-quality cancer studies.
Read more: https://bit.ly/3UtCdOa
#WorldCancerResearchDay #CancerResearch #ECACC
Read more: https://bit.ly/3UtCdOa
#WorldCancerResearchDay #CancerResearch #ECACC
📬 Stay connected after #ELRIGDD26. Visit Stand J01 to sign up for our newsletter and receive updates on ECACC products, resources, and events. https://bit.ly/4tUSrfd
@elrig.org #ECACC #DrugDiscovery #LifeSciences
@elrig.org #ECACC #DrugDiscovery #LifeSciences
October 15, 2026 at 1:00 PM
📬 Stay connected after #ELRIGDD26. Visit Stand J01 to sign up for our newsletter and receive updates on ECACC products, resources, and events. https://bit.ly/4tUSrfd
@elrig.org #ECACC #DrugDiscovery #LifeSciences
@elrig.org #ECACC #DrugDiscovery #LifeSciences
🧬 Discover ECACC's authenticated cancer cell lines at #ELRIGDD26. Visit Stand J01 to learn how they support oncology and drug discovery research.
@elrig.org #ECACC #DrugDiscovery #UKHSA
@elrig.org #ECACC #DrugDiscovery #UKHSA
October 15, 2026 at 9:11 AM
🧬 Discover ECACC's authenticated cancer cell lines at #ELRIGDD26. Visit Stand J01 to learn how they support oncology and drug discovery research.
@elrig.org #ECACC #DrugDiscovery #UKHSA
@elrig.org #ECACC #DrugDiscovery #UKHSA
🧫 Explore ECACC products and services at #ELRIGDD26. Visit Stand J01 to learn how authenticated cell culture resources can support your research.
@elrig.org #ECACC #DrugDiscovery #LifeSciences
@elrig.org #ECACC #DrugDiscovery #LifeSciences
October 14, 2026 at 1:00 PM
🧫 Explore ECACC products and services at #ELRIGDD26. Visit Stand J01 to learn how authenticated cell culture resources can support your research.
@elrig.org #ECACC #DrugDiscovery #LifeSciences
@elrig.org #ECACC #DrugDiscovery #LifeSciences
👋 Day 1 of #ELRIGDD26. Visit Stand J01 to meet the Culture Collections team and discover resources that support drug discovery and life sciences research. @elrig.org
#DrugDiscovery #ECACC #LifeSciences
#DrugDiscovery #ECACC #LifeSciences
October 14, 2026 at 10:59 AM
👋 Day 1 of #ELRIGDD26. Visit Stand J01 to meet the Culture Collections team and discover resources that support drug discovery and life sciences research. @elrig.org
#DrugDiscovery #ECACC #LifeSciences
#DrugDiscovery #ECACC #LifeSciences
🔬 We're exhibiting at #ELRIGDD26 on 14-15 October. Visit the Culture Collections team at Stand J01 to discover how our biological resources support drug discovery and life sciences research. @elrig.org
#DrugDiscovery #ECACC #LifeSciences
#DrugDiscovery #ECACC #LifeSciences
October 14, 2026 at 9:14 AM
🔬 We're exhibiting at #ELRIGDD26 on 14-15 October. Visit the Culture Collections team at Stand J01 to discover how our biological resources support drug discovery and life sciences research. @elrig.org
#DrugDiscovery #ECACC #LifeSciences
#DrugDiscovery #ECACC #LifeSciences
Karpas 707 is a human multiple myeloma cell line that secretes λ light chain and carries the Philadelphia chromosome. It is a valuable model for studying plasma cell malignancies, chromosome abnormalities, and bone disease associated with myeloma. https://bit.ly/4z9jGpX #ECACC
September 30, 2026 at 4:47 PM
Karpas 707 is a human multiple myeloma cell line that secretes λ light chain and carries the Philadelphia chromosome. It is a valuable model for studying plasma cell malignancies, chromosome abnormalities, and bone disease associated with myeloma. https://bit.ly/4z9jGpX #ECACC
DLRP 20082610: A metastatic squamous cell lung carcinoma cell line with multiple chromosomal abnormalities, supporting drug resistance, anticancer therapy, and cancer genetics research. Find out more: https://bit.ly/472razB #CellLinesInAction #ECACC #UKHSA
September 28, 2026 at 5:55 PM
DLRP 20082610: A metastatic squamous cell lung carcinoma cell line with multiple chromosomal abnormalities, supporting drug resistance, anticancer therapy, and cancer genetics research. Find out more: https://bit.ly/472razB #CellLinesInAction #ECACC #UKHSA
SK-N-BE(2) is a widely used neuroblastoma cell line with reported N-myc amplification, making it an important model for high-risk neuroblastoma, cancer genetics and oncogene regulation research. Find out more: https://bit.ly/4wkT2YK #CellLinesInAction #ECACC #UKHSA
September 25, 2026 at 4:09 PM
SK-N-BE(2) is a widely used neuroblastoma cell line with reported N-myc amplification, making it an important model for high-risk neuroblastoma, cancer genetics and oncogene regulation research. Find out more: https://bit.ly/4wkT2YK #CellLinesInAction #ECACC #UKHSA
A key tool in oral cancer research. Derived from a human tongue squamous cell carcinoma, this cell line is widely used to investigate cancer progression, apoptosis and treatment response. Find out more: https://bit.ly/4g8WtvA #CancerResearch #CellLinesInAction #UKHSA #ECACC
September 23, 2026 at 3:54 PM
A key tool in oral cancer research. Derived from a human tongue squamous cell carcinoma, this cell line is widely used to investigate cancer progression, apoptosis and treatment response. Find out more: https://bit.ly/4g8WtvA #CancerResearch #CellLinesInAction #UKHSA #ECACC
HOS R970-5 is a trusted osteogenic sarcoma model for studying bone cancer progression, viral replication, and drug resistance. Its high sensitivity to chemical and viral testing makes it a valuable platform for cancer research. https://bit.ly/4q3upy2 #CellLinesInAction #ECACC
September 21, 2026 at 3:53 PM
HOS R970-5 is a trusted osteogenic sarcoma model for studying bone cancer progression, viral replication, and drug resistance. Its high sensitivity to chemical and viral testing makes it a valuable platform for cancer research. https://bit.ly/4q3upy2 #CellLinesInAction #ECACC
U-2 OS is a bone sarcoma cell line widely used in bone biology, cancer, and arthritis research. Its epithelial-like morphology also makes it ideal for advanced cell imaging applications. View profile: https://bit.ly/4hstEfT
#CancerResearch #CellLinesInAction #BoneCancer #ECACC
#CancerResearch #CellLinesInAction #BoneCancer #ECACC
September 15, 2026 at 5:11 PM
U-2 OS is a bone sarcoma cell line widely used in bone biology, cancer, and arthritis research. Its epithelial-like morphology also makes it ideal for advanced cell imaging applications. View profile: https://bit.ly/4hstEfT
#CancerResearch #CellLinesInAction #BoneCancer #ECACC
#CancerResearch #CellLinesInAction #BoneCancer #ECACC
We have a job vacancy for an ECACC Operations Lead at UKHSA to lead manufacturing, quality control, and human genetic services operations while ensuring regulatory compliance and managing operational teams. Learn more and apply today https://bit.ly/4gTPeYA #UKHSA #ECACC #Vacancy
September 15, 2026 at 3:54 PM
We have a job vacancy for an ECACC Operations Lead at UKHSA to lead manufacturing, quality control, and human genetic services operations while ensuring regulatory compliance and managing operational teams. Learn more and apply today https://bit.ly/4gTPeYA #UKHSA #ECACC #Vacancy
We have a job vacancy for an ECACC Operations Lead at UKHSA to lead manufacturing, quality control, and human genetic services operations while ensuring regulatory compliance and managing operational teams. Learn more and apply today https://bit.ly/4gTPeYA #UKHSA #ECACC #Vacancy
September 11, 2026 at 5:10 PM
We have a job vacancy for an ECACC Operations Lead at UKHSA to lead manufacturing, quality control, and human genetic services operations while ensuring regulatory compliance and managing operational teams. Learn more and apply today https://bit.ly/4gTPeYA #UKHSA #ECACC #Vacancy
SH-SY5Y is a neuroblastoma-derived cell line widely used in neurobiology research. Its ability to differentiate into neuron-like cells makes it a valuable model for studying neuronal function and disease. https://bit.ly/4q5xGNq #CellLinesInAction #CancerResearch #ECACC
September 11, 2026 at 4:23 PM
SH-SY5Y is a neuroblastoma-derived cell line widely used in neurobiology research. Its ability to differentiate into neuron-like cells makes it a valuable model for studying neuronal function and disease. https://bit.ly/4q5xGNq #CellLinesInAction #CancerResearch #ECACC
PNT2 is a non-malignant prostate epithelial cell line widely used as a healthy control in prostate cancer research. It supports studies of cancer progression, cell mechanics, and tumour invasiveness. https://bit.ly/4c7QuWo #CancerResearch #ProstateCancer #ECACC
September 9, 2026 at 3:50 PM
PNT2 is a non-malignant prostate epithelial cell line widely used as a healthy control in prostate cancer research. It supports studies of cancer progression, cell mechanics, and tumour invasiveness. https://bit.ly/4c7QuWo #CancerResearch #ProstateCancer #ECACC
PANC-1 is a pancreatic ductal adenocarcinoma cell line used to study tumour biology, treatment responses, and targeted therapies. Its neuroendocrine features also make it valuable for investigating emerging therapeutic approaches. View profile: https://bit.ly/4fMIJHT
#ECACC
#ECACC
September 7, 2026 at 5:37 PM
PANC-1 is a pancreatic ductal adenocarcinoma cell line used to study tumour biology, treatment responses, and targeted therapies. Its neuroendocrine features also make it valuable for investigating emerging therapeutic approaches. View profile: https://bit.ly/4fMIJHT
#ECACC
#ECACC
OE19 was established from an oesophageal gastric junction adenocarcinoma and is widely used to study carcinogenesis, chemotherapy response, targeted therapies, and apoptosis in oesophageal cancer research. View the profile: https://bit.ly/3Ulaxul #CellLinesInAction #ECACC
September 4, 2026 at 4:24 PM
OE19 was established from an oesophageal gastric junction adenocarcinoma and is widely used to study carcinogenesis, chemotherapy response, targeted therapies, and apoptosis in oesophageal cancer research. View the profile: https://bit.ly/3Ulaxul #CellLinesInAction #ECACC
Nb2-11 is a rat lymphoma cell line widely used to study hormone-driven cell proliferation, tumour growth, anticancer therapies, and prolactin binding mechanisms.
View the profile: https://bit.ly/4wkLFAz #CancerResearch #CellLinesInAction #CultureCollections #ECACC
View the profile: https://bit.ly/4wkLFAz #CancerResearch #CellLinesInAction #CultureCollections #ECACC
September 2, 2026 at 3:45 PM
Nb2-11 is a rat lymphoma cell line widely used to study hormone-driven cell proliferation, tumour growth, anticancer therapies, and prolactin binding mechanisms.
View the profile: https://bit.ly/4wkLFAz #CancerResearch #CellLinesInAction #CultureCollections #ECACC
View the profile: https://bit.ly/4wkLFAz #CancerResearch #CellLinesInAction #CultureCollections #ECACC
From cancer research to biotherapeutic production, CHO-K1 cells remain one of the most widely used cell lines. They serve as healthy controls and host expression systems for antibodies, hormones, enzymes and more. Find out more: https://bit.ly/4z5Ft1C
#CellLinesInAction #ECACC
#CellLinesInAction #ECACC
August 28, 2026 at 4:04 PM
From cancer research to biotherapeutic production, CHO-K1 cells remain one of the most widely used cell lines. They serve as healthy controls and host expression systems for antibodies, hormones, enzymes and more. Find out more: https://bit.ly/4z5Ft1C
#CellLinesInAction #ECACC
#CellLinesInAction #ECACC
New catalogue addition: 97-7 (Cat. No. 21062326), a urothelial bladder cancer cell line from our Wisconsin panel. Used to study tumour heterogeneity, progression and therapeutic vulnerabilities in bladder cancer research. Learn more: https://bit.ly/3UizZ3M #CancerResearch #ECACC
August 27, 2026 at 2:46 PM
New catalogue addition: 97-7 (Cat. No. 21062326), a urothelial bladder cancer cell line from our Wisconsin panel. Used to study tumour heterogeneity, progression and therapeutic vulnerabilities in bladder cancer research. Learn more: https://bit.ly/3UizZ3M #CancerResearch #ECACC
A549 is a widely used lung cancer cell line originally isolated from a pulmonary adenocarcinoma patient. It supports research into lung cancer, respiratory biology, toxicology, and drug responses.
View profile: https://bit.ly/3ShQ5tS #LungCancer #A549 #ECACC #CellLinesInAction
View profile: https://bit.ly/3ShQ5tS #LungCancer #A549 #ECACC #CellLinesInAction
August 20, 2026 at 3:47 PM
A549 is a widely used lung cancer cell line originally isolated from a pulmonary adenocarcinoma patient. It supports research into lung cancer, respiratory biology, toxicology, and drug responses.
View profile: https://bit.ly/3ShQ5tS #LungCancer #A549 #ECACC #CellLinesInAction
View profile: https://bit.ly/3ShQ5tS #LungCancer #A549 #ECACC #CellLinesInAction
Colorectal cancer is the third most common cancer worldwide. ECACC offers 60+ cell lines derived from colorectal tumours to support cancer research.
Browse the collection: https://bit.ly/3S2Ft1u #CancerResearch #ColorectalCancer #ECACC #CellLinesInAction
Browse the collection: https://bit.ly/3S2Ft1u #CancerResearch #ColorectalCancer #ECACC #CellLinesInAction
August 18, 2026 at 4:53 PM
Colorectal cancer is the third most common cancer worldwide. ECACC offers 60+ cell lines derived from colorectal tumours to support cancer research.
Browse the collection: https://bit.ly/3S2Ft1u #CancerResearch #ColorectalCancer #ECACC #CellLinesInAction
Browse the collection: https://bit.ly/3S2Ft1u #CancerResearch #ColorectalCancer #ECACC #CellLinesInAction
Access verified oesophageal adenocarcinoma (EAC) cell lines with genotyping data from ECACC. Authenticated human cancer cell lines compared to original donor tumour tissue. Browse the collection: https://bit.ly/4e7G62B #CancerResearch #ECACC #OesophagealCancer
August 14, 2026 at 4:30 PM
Access verified oesophageal adenocarcinoma (EAC) cell lines with genotyping data from ECACC. Authenticated human cancer cell lines compared to original donor tumour tissue. Browse the collection: https://bit.ly/4e7G62B #CancerResearch #ECACC #OesophagealCancer